Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 52 | 0 | 5 | 0 | 300,90 € | 412,61 € | 37,12 % |
| Neurocrine Bioscience | 50 | 0 | 4 | 0 | 112,80 € | 148,27 € | 31,44 % |
| Ionis Pharmaceuticals Inc. | 48 | 1 | 1 | 0 | 68,00 € | 76,63 € | 12,69 % |
| Insulet Corp. | 46 | 0 | 0 | 0 | 220,00 € | 316,87 € | 44,03 % |
| Tenet Healthcare | 41 | 0 | 4 | 0 | 167,00 € | 176,55 € | 5,72 % |
| Jazz Pharmaceuticals plc | 38 | 0 | 3 | 0 | 141,15 € | 171,00 € | 21,15 % |
| Exelixis Inc. | 36 | 1 | 2 | 1 | 36,27 € | 40,97 € | 12,97 % |
| Acadia Pharmaceuticals | 31 | 1 | 3 | 0 | 22,60 € | 27,56 € | 21,94 % |
| PTC Therapeutics Inc. | 31 | 2 | 1 | 0 | ? | 67,74 € | 5,85 % |
| Merit Medical Systems | 27 | 0 | 0 | 0 | ? | 94,20 € | 36,52 % |
| Ultragenyx Pharmaceutical Inc. | 25 | 0 | 8 | 0 | ? | 57,43 € | 184,33 % |
| Arrowhead Pharmaceuticals Inc. | 23 | 0 | 4 | 0 | 56,64 € | 68,62 € | 21,16 % |
| United Therapeutics | 23 | 1 | 2 | 0 | 397,80 € | 481,07 € | 20,93 % |
| Charles River Labs Intl | 21 | 0 | 2 | 0 | 186,90 € | 172,91 € | -7,48 % |
| Haemonetics Corp. | 21 | 1 | 2 | 0 | 58,00 € | 76,62 € | 32,10 % |
| Bio-Techne Corp. | 18 | 0 | 0 | 0 | 56,50 € | 60,82 € | 7,65 % |
| Halozyme Therapeutics Inc. | 20 | 2 | 1 | 0 | 59,36 € | 68,68 € | 15,69 % |
| Bruker Corp. | 17 | 0 | 2 | 0 | 40,39 € | 46,21 € | 14,40 % |
| LivaNova plc | 17 | 0 | 1 | 0 | ? | 58,20 € | 7,79 % |
| Molina Healthcare | 18 | 1 | 2 | 0 | 155,75 € | 288,50 € | 85,23 % |
| Alkermes plc | 17 | 0 | 0 | 0 | ? | 38,70 € | 40,23 % |
| Repligen Corp. | 18 | 1 | 1 | 0 | 136,20 € | 154,75 € | 13,62 % |
| Iovance Biotherapeutics Inc. | 18 | 2 | 0 | 0 | 2,50 € | 14,29 € | 471,73 % |
| Icon plc | 16 | 0 | 0 | 0 | 156,75 € | 197,56 € | 26,04 % |
| Masimo Corp. | 14 | 0 | 0 | 0 | 118,00 € | 172,00 € | 45,76 % |

